Stocks and Investing Stocks and Investing
Thu, August 13, 2020

David Nierengarten Maintained (SWTX) at Buy with Increased Target to $50 on, Aug 13th, 2020


Published on 2024-10-27 12:07:20 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $48 to $50 on, Aug 13th, 2020.

David has made no other calls on SWTX in the last 4 months.



There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $58 on, Tuesday, April 14th, 2020
Contributing Sources